Skip to main content

Peanut Allergy clinical trials at UC Health
3 in progress, 0 open to new patients

  • AR101 Real-World Open-Label Extension Study

    Sorry, in progress, not accepting new patients

    This study is enrolling participants by invitation only. This is an open-label, safety extension study for subjects who participated in the ARC007 study.

    at UCSD UCSF UCLA

  • Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

    Sorry, accepting new patients by invitation only

    The purpose of this study is to assess AR101's safety and tolerability over an extended dosing period.

    at UCSF UCLA

  • PALISADE Follow-on Study (ARC004)

    Sorry, in progress, not accepting new patients

    The purpose of this study is to demonstrate the safety, tolerability, and efficacy of AR101 through characterized oral desensitization immunotherapy (CODIT) in peanut-allergic children and adults who have completed the ARC003 study.

    at UCSF UCLA

Last updated: